MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.

M, Flower; V, Lomeikaite; M, Ciosi; S, Cumming; F, Morales; k, Lo; D, Hensman Moss; L, Jones; P, Holmans; D, G Monckton; S, Tabrizi; the OPTIMISTIC Consortium, ; the TRACK-HD,

Year:

2019

Type of Publication:

Article

Journal:

Brain

Volume:

142

Number:

7

Pages:

1876–1886

DOI:

https://doi.org/10.1093/brain/awz115